Status:
COMPLETED
Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA)
Lead Sponsor:
Erasme University Hospital
Conditions:
Methicillin Resistance
Staphylococcus Aureus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of a novel PCR-based laboratory test for rapid detection of MRSA carriers to prevent transmission of MRSA in the Belgian acute care hospital setti...
Detailed Description
Methicillin-resistant Staphylococcus aureus (MRSA) strains have become endemic pathogens in acute and chronic healthcare facilities in Belgium. MRSA infection is causing increased public concern as it...
Eligibility Criteria
Inclusion
- All patients admitted for more than 48h to a ward in which evaluation in the previous baseline period met the following:
- \> 80 % compliance with admission and discharge conventional culture screening, for the pooled admissions to all study wards;
- \> 80 % compliance with additional MRSA contact isolation procedures, based on a sample of 50 patient care contact observations per hospital in all study wards;
- pooled incidence of nosocomial MRSA acquisition ≥ 1.5 new cases /100 at risk admissions in the study wards.
Exclusion
- Patients staying 48h or less in the study wards
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
7400 Patients enrolled
Trial Details
Trial ID
NCT00846105
Start Date
February 1 2009
End Date
May 1 2010
Last Update
June 15 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Algemeen Ziekenhuis Sint-Jan AV
Bruges, Belgium, B-8000
2
ULB Hopital Erasme
Brussels, Belgium, B-1070